Literature DB >> 21087216

Tolerogenic T cells, Th1/Th17 cytokines and TLR2/TLR4 expressing dendritic cells predominate the microenvironment within distinct oral mucosal sites.

J-P Allam1, Y Duan, J Winter, G Stojanovski, F Fronhoffs, M Wenghoefer, T Bieber, W-M Peng, N Novak.   

Abstract

BACKGROUND: Most local oral vaccine strategies use the sublingual region for drug application. Only little is known about the cytokine micromilieu, the nature of T cell subtypes and expression of target structures for adjuvants at different oral mucosal regions (OMR). However, targeting the optimal OMR might ensure highest efficiency of drug uptake and lowest risk for adverse effects.
METHODS: Expression of TGF-β1, IL10 as well as Th1, Th2 and Th17 cytokines and transcription factors was investigated at different OMR and skin by quantitative real-time PCR, immunohistochemistry or flow cytometry.
RESULTS: Highest number of T cells was located in vestibular/buccal region (VBR). In contrast to skin (SK), OMR T cells produced TGF-β1, IL-10, IFN-γ and IL-17. Significantly higher TGF-β1 mRNA expression in the VBR compared with the sublingual region (SLR) and skin could be detected, while equal transcripts of IL-10 and regulatory T cell-associated transcription factor FoxP3 could be demonstrated. Expression of Th17-associated IL-17A, IL-17F, IL-22 and IL-26 mRNA could be demonstrated in VBR and SLR but not in SK. Interestingly, compared to SK, significantly higher expression of TGF-β1 and IFN-γ could be detected in OMR. Moreover, expression of toll-like receptor (TLR) 2 and TLR4 was highest in VBR with significant expression on dendritic cells in OMR.
CONCLUSION: From this data, we conclude that (i) VBR and SLR represent a protolerogenic micromilieu, (ii) both regions form a Th1 cytokine-predominated microenvironment, but also express mRNA for Th17 cytokines and (iii) TLRs detectable in VBR and SLR might serve as a target structures for adjuvants.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087216     DOI: 10.1111/j.1398-9995.2010.02510.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  14 in total

Review 1.  Dendritic cells of the oral mucosa.

Authors:  A-H Hovav
Journal:  Mucosal Immunol       Date:  2013-06-12       Impact factor: 7.313

Review 2.  Pathogenic CD4+ T cells in patients with asthma.

Authors:  Lyndsey M Muehling; Monica G Lawrence; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2017-04-22       Impact factor: 10.793

Review 3.  The Role of Early Life Microbiota Composition in the Development of Allergic Diseases.

Authors:  Maimaiti Tuniyazi; Shuang Li; Xiaoyu Hu; Yunhe Fu; Naisheng Zhang
Journal:  Microorganisms       Date:  2022-06-09

4.  Sublingual immunotherapy: World Allergy Organization position paper 2013 update.

Authors:  Giorgio Walter Canonica; Linda Cox; Ruby Pawankar; Carlos E Baena-Cagnani; Michael Blaiss; Sergio Bonini; Jean Bousquet; Moises Calderón; Enrico Compalati; Stephen R Durham; Roy Gerth van Wijk; Désirée Larenas-Linnemann; Harold Nelson; Giovanni Passalacqua; Oliver Pfaar; Nelson Rosário; Dermot Ryan; Lanny Rosenwasser; Peter Schmid-Grendelmeier; Gianenrico Senna; Erkka Valovirta; Hugo Van Bever; Pakit Vichyanond; Ulrich Wahn; Osman Yusuf
Journal:  World Allergy Organ J       Date:  2014-03-28       Impact factor: 4.084

5.  Multidimensional study of the oral microbiome, metabolite, and immunologic environment in peanut allergy.

Authors:  Hsi-En Ho; Yoojin Chun; Stephanie Jeong; Oranicha Jumreornvong; Scott H Sicherer; Supinda Bunyavanich
Journal:  J Allergy Clin Immunol       Date:  2021-04-02       Impact factor: 14.290

6.  A Lipopolysaccharide from Pantoea Agglomerans Is a Promising Adjuvant for Sublingual Vaccines to Induce Systemic and Mucosal Immune Responses in Mice via TLR4 Pathway.

Authors:  Masahiro Fukasaka; Daisuke Asari; Eiji Kiyotoh; Arimichi Okazaki; Yasuyuki Gomi; Takeshi Tanimoto; Osamu Takeuchi; Shizuo Akira; Mitsuhiko Hori
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

7.  Dendritic Cell Subsets in Oral Mucosa of Allergic and Healthy Subjects.

Authors:  Susanne M Reinartz; Joost van Tongeren; Danielle van Egmond; Esther J J de Groot; Wytske J Fokkens; Cornelis M van Drunen
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

8.  Physical activity, black carbon exposure, and DNA methylation in the FOXP3 promoter.

Authors:  Stephanie Lovinsky-Desir; Kyung Hwa Jung; Jacqueline R Jezioro; David Z Torrone; Mariangels de Planell-Saguer; Beizhan Yan; Frederica P Perera; Andrew G Rundle; Matthew S Perzanowski; Steven N Chillrud; Rachel L Miller
Journal:  Clin Epigenetics       Date:  2017-06-13       Impact factor: 6.551

9.  IL-26 promotes the proliferation and survival of human gastric cancer cells by regulating the balance of STAT1 and STAT3 activation.

Authors:  Wei You; Qiyun Tang; Chuanyong Zhang; Jindao Wu; Chunrong Gu; Zhengshan Wu; Xiangcheng Li
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.752

10.  Comparative analysis of the oral mucosae from rodents and non-rodents: Application to the nonclinical evaluation of sublingual immunotherapy products.

Authors:  Catherine Thirion-Delalande; Frédéric Gervais; Cécile Fisch; Jean Cuiné; Véronique Baron-Bodo; Philippe Moingeon; Laurent Mascarell
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.